Remove Health Technology Remove Life Science Remove Medical Technology Remove Pharmaceuticals
article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. & LONDON–(BUSINESS WIRE)– The Committee to Restore Nymox Shareholder Value, Inc.

article thumbnail

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

Health Populi

That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 Key Medtech Themes for 2023

Henry Kotula

At the same time, medtech innovators – whether in digital health, wearables and AI-driven offerings in healthcare, or diagnostics, telemedicine and health IT solutions – continue to face a patchwork of laws, rules and norms across the world. Long-term adoption of telehealth and remote patient monitoring technologies.

article thumbnail

Our Homes as HealthQuarters – Finding Health and Well-Being at CES 2023

Health Populi

For over ten years, digital health technology has been a fast-growing area at the annual CES , the largest convention covering consumer electronics in the world. The company is offering a hearing device integrating deep neural network technology that offers “BrainHearing through the ear” in a customized hearing aid.